{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":23,"n_cols":5,"rows_kept":23,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[4,2,4,3],[7,2,7,3],[8,2,8,3],[9,2,9,3],[11,2,11,3],[12,2,12,3],[16,2,16,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910131544103321"]
[null,null,"Titolo",null,"Clinical guide to transplantation in lymphoma / / edited by Bipin N. Savani, MD, Mohamad Mohty, MD, PhD"]
[null,null,"Pubbl/distr/stampa",null,"Chichester, [England] : , : Wiley Blackwell, , 2015"]
[{"$nulls":4},"©2015"]
[null,null,"ISBN",null,"1-118-86327-5"]
[{"$nulls":4},"1-118-86326-7"]
[{"$nulls":4},"1-118-86328-3"]
[null,null,"Descrizione fisica",null,"1 online resource (288 p.)"]
[null,null,"Disciplina",null,"616.99446"]
[null,null,"Soggetti",null,"Lymphomas - Surgery"]
[{"$nulls":4},"Stem cells - Transplantation"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references at the end of each chapters and index."]
[null,null,"Nota di contenuto",null,"Title page; Copyright page; Contents; List of contributors; Foreword; Introduction; Declaration of commercial interest; References; Section 1 Transplantation in lymphomas; Chapter 1 Lymphoma and transplantation: historical perspective; Brief history of hematopoietic cell transplantation; History of autologous HCT in non-Hodgkin lymphoma; History of autologous HCT in Hodgkin lymphoma; History of allogeneic HCT in lymphoma; General historical considerations; References; Chapter 2 Lymphoma: working committee and data reporting after transplantation in lymphoma; Introduction; Registry structure"]
[{"$nulls":4},"Working committees Data reporting; Overcoming challenges to data reporting; Flow of data; Data quality; The Lymphoma Working Committee; Statistical methods; Type of data; Intervals and patient selection; Unadjusted comparison; Adjusted comparison; Selected examples from the CIBMTR Lymphoma Committee; Value for young investigators; Value for public and other stakeholders; Conclusion; References; Chapter 3 Use of transplantation in lymphoma: adults; Introduction; Hodgkin lymphoma; Non-Hodgkin lymphoma; Diffuse large B-cell lymphoma; Follicular lymphoma; Histologic transformation to DLBCL"]
[{"$nulls":4},"Mantle cell lymphoma Burkitt lymphoma; Primary CNS lymphoma; Peripheral T-cell lymphoma; Prognostic tools; Maintenance therapies; "]
[{"$nulls":4},"Novel therapies; Conclusions; References; Chapter 4 Hematopoietic stem cell transplantation for lymphoma in children, adolescents, and young adults; Introduction; Principles of autologous and allogeneic HSCT in pediatric lymphomas; Hodgkin lymphoma; Lymphoblastic lymphoma; Anaplastic large-cell lymphoma; Mature B-cell lymphomas: Burkitt lymphoma, diffuse large B-cell lymphoma, and primary mediastinal B-cell lymphoma; Future directions; Conclusions; References"]
[{"$nulls":4},"Chapter 5 Preparative regimens for lymphoma: autologous hematopoietic stem cell transplantation Rationale for chemotherapy dose intensification for disease eradication; Traditional preparative regimens; Incorporation of monoclonal antibodies in autologous HCT preparative regimens; Rituximab; Monoclonal antibodies conjugated to radionuclide; Novel agents used in preparative regimens; Future directions; References; Chapter 6 Preparative regimens for lymphoma: allogeneic hematopoietic stem cell transplantation; Introduction; Myeloablative conditioning regimens for lymphomas"]
[{"$nulls":4},"Reduced-intensity conditioning regimens RIC allo-HCT in diffuse large B-cell lymphoma; RIC allo-HCT for follicular lymphoma; RIC allo-HCT in mantle cell lymphoma; RIC allo-HCT in Hodgkin lymphoma; Incorporating monoclonal antibodies in preparative regimens for allo-HCT; Alternative donor sources; Umbilical cord blood cells; Haploidentical transplantation; Vaccine strategies in allo-HCT; Discussion and future direction; References; Chapter 7 Pretransplantation evaluation, comorbidities, and nondisease-related eligibility criteria for transplantation in lymphoma; Introduction; Initial steps"]
[{"$nulls":4},"Preparation for transplant center evaluation"]